Retatrutide 5mg + Cagrilintide 5mg
Retatrutide 5 mg + Cagrilintide 5 mg is a vendor-formulated research peptide combination composed of two investigational peptides with distinct but potentially complementary mechanisms of action. Current scientific understanding of this formulation is derived primarily from research on its individual components rather than the combination as a single experimental system.
Retatrutide 5mg + Cagrilintide 5mg
Sale!7%
Retatrutide 5 mg + Cagrilintide 5 mg is a vendor-formulated research peptide combination composed of two investigational peptides with distinct but potentially complementary mechanisms of action. Current scientific understanding of this formulation is derived primarily from research on its individual components rather than the combination as a single experimental system.
$190.00
Buy more, save more!
-
Save 1%
Buy 3, get $2.50 off each
$190.00Per item: $187.50Total price: $562.50 -
Save 2%
Buy 5, get $3.75 off each
$190.00Per item: $186.25Total price: $931.25 -
Save 4%
Buy 10, get $7.50 off each
$190.00Per item: $182.50Total price: $1,825.00
$205.00$190.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
Retatrutide is an investigational peptide that functions as a triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Cagrilintide is a long-acting amylin analogue that has been investigated for its interactions with amylin receptor signalling and its role in endocrine physiology.
Because these peptides act through distinct hormonal pathways, researchers have expressed interest in understanding how incretin and amylin signalling may interact within complex metabolic and endocrine networks. However, these mechanistic concepts remain hypothetical for the retatrutide–cagrilintide combination, as no dedicated studies have directly evaluated their combined pharmacology.
Published studies have independently characterized the receptor pharmacology, intracellular signalling mechanisms, pharmacokinetic properties, and biological activities of retatrutide and cagrilintide. These investigations have expanded scientific understanding of incretin biology, amylin signalling, endocrine communication, and molecular mechanisms involved in metabolic regulation.
Potential Research Areas
- GLP-1 receptor signalling studies
- GIP receptor pathway investigations
- Glucagon receptor signalling research
- Amylin receptor signalling studies
- Incretin biology research
- Peptide pharmacology
- Endocrine signalling research
- Molecular physiology investigations
- Cellular signal transduction studies
| Strength Variation |
|---|
There are no reviews yet.